Veterinary Medicine Information website

Cryomarex Rispens Zawiesina i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań

Not authorised
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live

Product identification

Medicine name:
Cryomarex Rispens Zawiesina i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań
Active substance:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Target species:
  • Chicken (hen)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
    0.60
    plaque forming unit
    /
    1.00
    plaque forming unit
Pharmaceutical form:
  • Concentrate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (hen)
      • All relevant tissues
        0
        day
  • Subcutaneous use
    • Chicken (hen)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Authorisation status:
  • Surrendered
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
  • Laboratoire Bioluz
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0478
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 7/06/2023

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 7/06/2023